The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Levodopa‐induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys
Abstract
Antagonists of the N‐methyl‐D‐aspartate (NMDA) subtype of glutamate receptor have been reported to potentiate the antiparkinsonian action of levodopa and reverse levodopa‐induced motor fluctuations in animal models of Parkinson's disease. To evalute the effect of NMDA receptor blockade on dyskinesias complicating the response to long‐term levodopa therapy, we studied the selective antagonist LY235959 in six 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐lesioned monkeys. Drugs were administered subcutaneously, LY235959 at doses of 0.5, 1.0, 3.0, and 5.0 mg/kg and levodopa/benserazide at doses that produced moderate dyskinesias while almost totally reversing parkinsonian signs. Compared with vehicle control injections, LY235959 (3.0 mg/kg) abolished oral dyskinesias and diminished choreic dyskinesias by 68% (P < 0.01). Lower doses had smaller effects, although still significant, on oral dyskinesias (55% reduction at 1.0 mg/kg, P < 0.05). The highest LY235959 dose (5.0 mg/kg) prolonged oral dyskinesia suppression, but tended to increase dystonia severity. LY235959 had no effect on motor function when given alone and did not reduce the antiparkinsonian response to levodopa. These findings suggest that NMDA receptor blockade may ameliorate the dyskinetic complications of long‐term levodopa therapy, without diminishing the beneficial effects on parkinsonian signs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Self-citationReversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 961
Stereotactic ventral pallidotomy for Parkinson's disease
Dogali, M., Fazzini, E., Kolodny, E., Eidelberg, D., Sterio, D., Devinsky, O., & Beric, A. (1995) · Neurology · doi:10.1212/wnl.45.4.753 · Cited by 394
Standaert, D. G., Testa, C. M., Young, A. B., & Penney, J. B. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903430102 · Cited by 370
Albin, R. L., Makowiec, R. L., Hollingsworth, Z. R., Dure, L. S., Penney, J. B., & Young, A. B. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90006-n · Cited by 367
NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats
Klockgether, T., & Turski, L. (1990) · Annals of Neurology · doi:10.1002/ana.410280411 · Cited by 284
Kasanetz, F., Riquelme, L. A., O'Donnell, P., & Murer, M. G. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113050 · Cited by 281
Papa, S. M., Engber, T. M., Kask, A. M., & Chase, T. N. (1994) · Brain Research · doi:10.1016/0006-8993(94)90796-x · Cited by 235
Self-citationEngber, T. M., Susel, Z., Kuo, S., Gerfen, C. R., & Chase, T. N. (1991) · Brain Research · doi:10.1016/0006-8993(91)90667-k · Cited by 194
Self-citation
Cited by
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,201
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
Functional changes of the basal ganglia circuitry in Parkinson's disease
Blandini, F., Nappi, G., Tassorelli, C., & Martignoni, E. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00067-2 · Cited by 582
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
Metadata
- Authors
- Papa, S. M., & Chase, T. N.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1996-05
- Volume
- 39
- Issue
- 5
- Pages
- 574-578
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2113826471
- Cited by
- 292
- References
- 18
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Levodopa‐induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys. https://app.cochat.ai/papers/10.1002/ana.410390505
- The paper
- Papa, S. M., & Chase, T. N. (1996). Levodopa‐induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys. Annals of Neurology. https://doi.org/10.1002/ana.410390505
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.